Not applicableStudy completedNCT00787904What this trial is testingRole of T-cells in Post-Menopausal OsteoporosisWho this might be right forOsteoporosis Atlanta VA Medical Center 19
Not applicableStudy completedNCT04169789What this trial is testingPrevention of Early Postmenopausal Bone Loss With Lactobacillus ReuteriWho this might be right forPostmenopausal Osteoporosis Sahlgrenska University Hospital 239
Large-scale testing (Phase 3)Study completedNCT00909961What this trial is testingA Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 YearsWho this might be right forPostmenopausal Osteoporosis Novartis Pharmaceuticals 118
Not applicableStudy completedNCT01381588What this trial is testingThe Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal WomenWho this might be right forOsteoporosis, Postmenopausal GlaxoSmithKline 1,136
Post-approval studies (Phase 4)Study completedNCT05903820What this trial is testingRhythmic Estradiol and Bone HealthWho this might be right forOsteoporosis RiskMenopause Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48
Post-approval studies (Phase 4)Study completedNCT00549068What this trial is testingPOWER Point of Care Effect on Satisfaction of TreatmentWho this might be right forOsteoporosis, Postmenopausal Sanofi 2,433
Post-approval studies (Phase 4)UnknownNCT05645289What this trial is testingEfficacy and Safety of Minodronate in Patients With Low Back PainWho this might be right forPostmenopausal Osteoporosis Peking University Third Hospital 72
Post-approval studies (Phase 4)UnknownNCT04719650What this trial is testingClinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic AcidWho this might be right forPostmenopausal Osteoporosis Peking University Third Hospital 64
Testing effectiveness (Phase 2)Study completedNCT00533650What this trial is testingProof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)Who this might be right forPost-Menopausal Osteoporosis Merck Sharp & Dohme LLC 227
Testing effectiveness (Phase 2)Study completedNCT00535860What this trial is testingEfficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With OsteoporosisWho this might be right forOsteoporosis TransPharma Medical 104
Not applicableStudy completedNCT00567606What this trial is testingPrevention of Osteoporosis in Breast Cancer SurvivorsWho this might be right forPostmenopausal Osteoporosis University of Nebraska 249
Testing effectiveness (Phase 2)Study completedNCT00674453What this trial is testingThe Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine EvaluationWho this might be right forBone Loss Ligand Pharmaceuticals 51
Post-approval studies (Phase 4)Study completedNCT00259298What this trial is testingEvaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With OsteoporosisWho this might be right forOsteoporosis Eli Lilly and Company 12
Not applicableStudy completedNCT05346419What this trial is testingAntiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal PatientsWho this might be right forPostmenopausal OsteoporosisHypovitaminosis DHyperparathyroidism Hospital Regional 1o de Octubre 33
Not applicableStudy completedNCT03227458What this trial is testingDHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older WomenWho this might be right forLow Bone MassOsteoporosis, Postmenopausal University of Colorado, Denver 152
Not applicableStudy completedNCT05025917What this trial is testingAssessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal WomenWho this might be right forMuscle WeaknessOsteoporosis, Postmenopausal University of Exeter 24
Large-scale testing (Phase 3)Study completedNCT01348243What this trial is testingEfficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal OsteoporosisWho this might be right forPostmenopausal Osteoporosis Chiesi Farmaceutici S.p.A. 260
Early research (Phase 1)Study completedNCT01526278What this trial is testingPharmacokinetics of Maxmarvil® in Healthy Postmenopausal WomenWho this might be right forOsteoporosis Yuyu Pharma, Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT01928082What this trial is testingThe Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone MassWho this might be right forHypercalciuriaHypercalciuria, Familial IdiopathicOsteopenia+1 more University of Chicago 1
Early research (Phase 1)Study completedNCT01068262What this trial is testingSafety and Tolerability of Odanacatib (0822-059)Who this might be right forOsteoporosis Merck Sharp & Dohme LLC 44